Major
Acetylsalicylic acid × Furosemide
Antiplatelet agents (low dose) / NSAIDs (analgesic dose)×Loop diuretics
Mechanism
Dual mechanism: aspirin competes with furosemide for organic anion tubular secretion in the renal tubules (so furosemide does not reach its target in the loop of Henle lumen), and concurrently suppresses renal prostaglandin synthesis supporting glomerular perfusion.
Symptoms
Reduced urine output, worsening oedema, weight gain. In heart failure: dyspnoea, orthopnoea. Blood pressure and creatinine may rise.
Management
At low aspirin doses (75–100 mg for cardioprotection), the clinical effect is minimal. At full anti-inflammatory doses, furosemide-induced diuresis drops markedly – titrate furosemide clinically or temporarily withhold aspirin during decompensation.
Sources
- ESC: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2021)– Eur Heart J 2021;42(36):3599–3726
- FDA: FDA Drug Safety Communication: FDA strengthens warning that non-aspirin NSAIDs can cause heart attacks or strokes (2015)– FDA Drug Safety Communication, July 9, 2015
- AHA: Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association (2016)– Circulation 2016;134(6):e32–e69